2026 Pancreatic Cancer Symposium

This conference has already taken place.

Ohio State University will host a Pancreas Symposium on Friday, May 8th, bringing together national leaders in pancreatic cancer care and research, including Dr. Theodore S. Hong of Harvard Medical School and Massachusetts General Hospital and Dr. Jen Jen Yeh of the University of North Carolina. This symposium is designed for clinicians and researchers committed to advancing the early detection, diagnosis, and comprehensive management of pancreatic disease. Participants will gain practical insights to increase clinician awareness of early and subtle signs and risk factors, promote standardized, evidence-based diagnostic pathways, and translate emerging advances, such as precision medicine and biomarker-driven therapies, into real-world practice. The program will also emphasize supportive care across the disease continuum, including pancreatic exocrine insufficiency (PEI) management, nutrition, and rehabilitation, while addressing care disparities and fostering equitable, patient-centered care.

• Additional Info
• Agenda
• Pricing
• Speakers
• Location
• Accreditation & Credit Statements

Dates and Times

Start: 5/8/2026 7:00 AM
End: 5/8/2026 4:00 PM

Objectives

1. Define the diagnostic studies needed to accurately diagnose and stage patients with pancreatic cancer

2. Review multimodality stage-specific treatment sequencing for patient with pancreatic cancer

3.Review available clinical trials for patients with pancreatic cancer.

Agenda

Pricing

Tier	Price
Physician	$60.00
Researcher	$60.00
Administrator	$60.00
Nurse/APP	$30.00
Fellow/Trainee/Student	$0.00
Other	$60.00

Speakers

• Josie Baker, Other
  • Beyond the Diagnosis: The Role of Genetic Testing in Pancreatic Cancer Care and Family Risk
• Alex Blair, MD
  • Advances in Vaccine Therapy for Pancreatic Cancer
• James Brehany, MD
  • Advances in Supportive Care in Pancreatic Cancer
• Wei Chen, MD
  • Pancreatic Cancer Pathology
• Zobeida Cruz-Monserrate, PhD
  • Strategies for the Prevention of Obesity-Associated Pancreatic Cancer
• Mary Dillhoff, MD
  • Building a Safe and Reliable HPB Team
• Kristin Foley, MD
  • CT Imaging of Pancreas Cancer
• Andrew Gunderson, PhD
  • Inducing Tertiary Lymphoid Structure to Promote Immunotherapy Response in PDAC
• HARRISON KIM, PhD
  • Dynamic Contrast-Enhanced Magnetic Resonance (DCE-MRI) for Early Therapy Response Assessment of Pancreatic Ductal Adenocarcinoma
• Anne Noonan, MD
  • Systemic Therapy Option for Pancreatic Cancer: A New Era Awaits
• Erica Park, MD
  • Endoscopic Approaches to Pancreatic Neoplasia
• Kenneth Pitter, MD
  • Targeted Therapies in Pancreatic Cancer - Thinking Outside the KRAS-Box
• Susan Tsai, MD
  • Localized Pancreatic Cancer: Rewriting the Playbook on Treatment Sequencing

Location

Mitchell Hall
250 Cleveland Ave.
Columbus, OH 43215

Accreditation Statement

The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Ohio State University designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credit(s) ^™. Physicians should only claim credit commensurate with the extent of their participation in the activity.